TABLE 3.
Ferritin nanoparticles in chemotherapy.
| Chemotherapeutic Drugs | Ferriatin Types | Indication(s) | Ref |
|---|---|---|---|
| Doxorubicin | human HFn | Targeting drug delivery | (Liang et al., 2014; Gu et al., 2020; Inoue et al., 2021) |
| Recombinant human HFn | Targeting drug delivery | Zhen et al. (2013) | |
| Recombinant HFt | Targeting drug delivery | Falvo et al. (2018) | |
| HoSF | Targeting drug delivery | (Kilic et al., 2012; Zhang et al., 2019a) | |
| PfFt | Hepatocellular carcinoma Targeting drug delivery |
Jiang et al. (2019b) | |
| Cisplatin | Recombinant human HFn | Targeting drug delivery | (Falvo et al., 2013; Monti et al., 2019) |
| HoSF | Targeting drug delivery | Xing et al. (2009) | |
| Oxaliplatin | Recombinant human HFn | Targeting drug delivery and photodynamic therapy | Liu et al. (2020b) |
| HoSF | Targeting drug delivery | Xing et al. (2009) | |
| Paclitaxel | Recombinant human HFn | Targeting drug delivery glioma | Liu et al. (2020c) |
| Epirubicin | HoSF | Targeting drug delivery | Tan et al. (2018) |
| Recombinant human HFn | Targeting drug delivery | Wang et al. (2022) | |
| Mitoxantrone | Recombinant human HFn | Targeting drug delivery Tumor therapy (colon, breast, sarcoma and pancreas) |
Falvo et al. (2018) |